This trial is testing whether a lower dose of radiation therapy spread out over a longer period of time is as effective at treating endometrial cancer as the standard higher dose given in a shorter timeframe.
2 Primary · 2 Secondary · Reporting Duration: 3 months
15 Total Participants · 1 Treatment Group
Primary Treatment: Hypofractionated WPRT · No Placebo Group · N/A
Age 18+ · Female Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: